AI-powered network accelerating drug development and patient access
Tandem connects doctors, patients, and clinical data to streamline how new therapies reach market. The stack—BigQuery, Dataform, Fivetran, PostgreSQL—reflects a data-first architecture for ingesting and modeling distributed medical information at scale. Active projects around multimodal AI bots and data extraction, paired with pain points around provider adoption friction and scaling to market demand, suggest the company is building toward automation of clinical workflows rather than pure analytics.
Notable leadership hires: Chief of Staff, Growth Lead
Tandem operates a network platform bridging physicians, patients, and first-party health data to accelerate drug development cycles and improve patient access to new medicines. Founded in 2023, the company is based in New York and backed by Thrive Capital, General Catalyst, and Bain Capital Ventures. With 51–200 employees, Tandem is scaling an engineering and sales organization to handle growing clinical throughput while optimizing internal workflows; active projects span hiring infrastructure, automation, and program design for biopharma customers.
Google Workspace, Jamf, Zoom, Slack, Twingate, BigQuery, Dataform, Fivetran, PostgreSQL, HubSpot, and Monday.com. The data layer emphasizes BigQuery, Dataform, and Fivetran for pipeline and modeling work.
New York, NY. The company is hiring exclusively in the United States as of the latest snapshot.
Other companies in the same industry, closest in size